PRXL2A was overexpressed in oral squamous cell carcinoma and renal clear cell carcinoma, where high PRXL2A was associated with poor prognosis (Chen et al., 2019b; Ren et al., 2021). This evidence concerns the gene PRXL2A and clear cell renal carcinoma.